345 related articles for article (PubMed ID: 20173776)
1. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
Chatenoud L
Nat Rev Endocrinol; 2010 Mar; 6(3):149-57. PubMed ID: 20173776
[TBL] [Abstract][Full Text] [Related]
2. CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.
Chatenoud L; Waldmann H
Rev Diabet Stud; 2012; 9(4):372-81. PubMed ID: 23804274
[TBL] [Abstract][Full Text] [Related]
3. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.
Chatenoud L; You S; Okada H; Kuhn C; Michaud B; Bach JF
Clin Exp Immunol; 2010 Apr; 160(1):106-12. PubMed ID: 20415859
[TBL] [Abstract][Full Text] [Related]
4. [Prevent and cure insulin-dependent diabetes].
Bach JF
Pathol Biol (Paris); 2003 Apr; 51(3):151-5. PubMed ID: 12781796
[TBL] [Abstract][Full Text] [Related]
5. [One step towards restoration of self-tolerance in human autoimmune diseases].
Chatenoud L
Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
[TBL] [Abstract][Full Text] [Related]
6. Reversal of New Onset Type 1 Diabetes by Oral
Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
Front Immunol; 2019; 10():320. PubMed ID: 30863412
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of insulin-dependent diabetes mellitus.
Masteller EL; Bluestone JA
Curr Opin Immunol; 2002 Oct; 14(5):652-9. PubMed ID: 12183168
[TBL] [Abstract][Full Text] [Related]
8. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
9. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.
Tan T; Xiang Y; Chang C; Zhou Z
Clin Rev Allergy Immunol; 2014 Oct; 47(2):234-43. PubMed ID: 25086642
[TBL] [Abstract][Full Text] [Related]
10. The role of immunomodulation therapy in autoimmune diabetes.
Ludvigsson J;
J Diabetes Sci Technol; 2009 Mar; 3(2):320-30. PubMed ID: 20144363
[TBL] [Abstract][Full Text] [Related]
11. Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.
Begum S; Chen W; Herold KC; Papaioannou VE
Endocrinology; 2009 Oct; 150(10):4512-20. PubMed ID: 19589867
[TBL] [Abstract][Full Text] [Related]
12. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
Am J Pathol; 2008 Apr; 172(4):972-9. PubMed ID: 18349126
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud L; Thervet E; Primo J; Bach JF
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
[TBL] [Abstract][Full Text] [Related]
14. Use of anti-CD3 monoclonal antibody to induce immune regulation in type 1 diabetes.
Bisikirska BC; Herold KC
Ann N Y Acad Sci; 2004 Dec; 1037():1-9. PubMed ID: 15699486
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
[TBL] [Abstract][Full Text] [Related]
16. Advances in immunotherapy of type I diabetes.
Ni Q; Pham NB; Meng WS; Zhu G; Chen X
Adv Drug Deliv Rev; 2019 Jan; 139():83-91. PubMed ID: 30528629
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy.
Peng B; Ye P; Rawlings DJ; Ochs HD; Miao CH
Blood; 2009 Nov; 114(20):4373-82. PubMed ID: 19770362
[TBL] [Abstract][Full Text] [Related]
18. Humanizing animal models: a key to autoimmune diabetes treatment.
Bresson D; von Herrath M
Sci Transl Med; 2011 Feb; 3(68):68ps4. PubMed ID: 21289271
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
20. The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice.
Sarikonda G; Sachithanantham S; Miller JF; Pagni PP; Coppieters KT; von Herrath M
J Autoimmun; 2015 May; 59():61-6. PubMed ID: 25772283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
